Viewing Study NCT02927457


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-01 @ 5:24 PM
Study NCT ID: NCT02927457
Status: COMPLETED
Last Update Posted: 2021-04-08
First Post: 2016-08-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Erythematosus, Cutaneous View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Spleen Tyrosine Kinase-SYK View
None Photoprovocation-PV View
None GSK2646264 View
None Cutaneous Lupus Erythematosus-CLE View